These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 72325)

  • 1. Teratogenesis and maternal progesterone.
    Roberts IF; West RJ
    Lancet; 1977 Nov; 2(8045):982. PubMed ID: 72325
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of suspected teratogenic holoprosencephaly.
    Stabile M; Bianco A; Iannuzzi S; Buonocore MC; Ventruto V
    J Med Genet; 1985 Apr; 22(2):147-9. PubMed ID: 3989833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Threatened abortion: patient characteristics, treatment results and consequences for the child].
    Eggimann UH; Thürig E; Moser H; Bossi E
    Schweiz Med Wochenschr; 1979 Feb; 109(8):288-92. PubMed ID: 571142
    [No Abstract]   [Full Text] [Related]  

  • 5. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy.
    Dudás I; Gidai J; Czeizel AE
    Congenit Anom (Kyoto); 2006 Dec; 46(4):194-8. PubMed ID: 17096820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of fetal anomalies as a result of progesterone therapy during pregnancy.
    Check JH; Rankin A; Teichman M
    Fertil Steril; 1986 Apr; 45(4):575-7. PubMed ID: 3956772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.
    Zaqout M; Aslem E; Abuqamar M; Abughazza O; Panzer J; De Wolf D
    Pediatr Cardiol; 2015 Oct; 36(7):1483-8. PubMed ID: 25972284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dydrogesterone (Duphaston) in the prevention of risk of ultrasound guided amniocentesis].
    Korczyński J
    Ginekol Pol; 2000 Aug; 71(8):709-13. PubMed ID: 11082907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apropos of the use of dydrogesterone in gynecology and obstetrics; clinical experience].
    Gellé P; Schaeffer P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1965; 17(4):369-70. PubMed ID: 5858369
    [No Abstract]   [Full Text] [Related]  

  • 13. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy maintenance after early luteectomy by 17-hydroxyprogesterone-capronate.
    Pulkkinen MO
    Acta Obstet Gynecol Scand; 1982; 61(4):347-9. PubMed ID: 7148409
    [No Abstract]   [Full Text] [Related]  

  • 16. Abortion: its prediction and management. Use of progestins in patients with arborization of cervical mucus smears.
    Jacobson BD
    Fertil Steril; 1965; 16(5):604-12. PubMed ID: 5833968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital abnormalities of the urinary tract in Mayer-Rokitansky-Kuster-Hauser syndrome].
    Malewski AW; Czaplicki M; Kryst P
    Ginekol Pol; 1992 May; 63(5):251-4. PubMed ID: 1304519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile.
    Blois SM; Joachim R; Kandil J; Margni R; Tometten M; Klapp BF; Arck PC
    J Immunol; 2004 May; 172(10):5893-9. PubMed ID: 15128769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
    Wang S; Wang XT; Liu RH; Liu M; Wu YR; Huang XY; Zhao N; Mu YL
    Ginekol Pol; 2017; 88(12):679-685. PubMed ID: 29303226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.